Citation: Cj. Kim et al., IMMUNODOMINANCE ACROSS HLA POLYMORPHISM - IMPLICATIONS FOR CANCER-IMMUNOTHERAPY, Journal of immunotherapy, 21(1), 1998, pp. 1-16
Authors:
FETSCH PA
MARINCOLA F
FILIE A
HIJAZI Y
ABATI A
Citation: Pa. Fetsch et al., MELANOMA-ASSOCIATED ANTIGEN RECOGNIZED BY T-CELLS (MART-1) - THE ADVENT OF A PREFERRED IMMUNOHISTOCHEMICAL ANTIBODY FOR THE DIAGNOSIS OF METASTATIC MALIGNANT-MELANOMA (MMM) IN FINE-NEEDLE ASPIRATIONS (FNA), Modern pathology, 11(1), 1998, pp. 37-37
Authors:
BRONTE V
CARROLL MW
GOLETZ TJ
WANG M
OVERWIJK WW
MARINCOLA F
ROSENBERG SA
MOSS B
RESTIFO NP
Citation: V. Bronte et al., ANTIGEN EXPRESSION BY DENDRITIC CELLS CORRELATES WITH THE THERAPEUTICEFFECTIVENESS OF A MODEL RECOMBINANT POXVIRUS TUMOR VACCINE, Proceedings of the National Academy of Sciences of the United Statesof America, 94(7), 1997, pp. 3183-3188
Authors:
JACOB L
SOMASUNDARAM R
SMITH W
MONOS D
BASAK S
MARINCOLA F
PEREIRA S
HERLYN D
Citation: L. Jacob et al., CYTOTOXIC T-CELL CLONE AGAINST RECTAL-CARCINOMA INDUCED BY STIMULATION OF A PATIENTS PERIPHERAL-BLOOD MONONUCLEAR-CELLS WITH AUTOLOGOUS CULTURED TUMOR-CELLS, International journal of cancer, 71(3), 1997, pp. 325-332
Authors:
BEATY MW
FETSCH P
WILDER AM
MARINCOLA F
ABATI A
Citation: Mw. Beaty et al., EFFUSION CYTOLOGY OF MALIGNANT-MELANOMA - A MORPHOLOGIC AND IMMUNOCYTOCHEMICAL ANALYSIS INCLUDING APPLICATION OF THE MART-1 ANTIBODY, Cancer cytopathology, 81(1), 1997, pp. 57-63
Authors:
PREMKUMAR A
MARINCOLA F
TAUBENBERGER J
CHOW C
VENZON D
SCHWARTZENTRUBER D
Citation: A. Premkumar et al., METASTATIC MELANOMA - CORRELATION OF MRI CHARACTERISTICS AND HISTOPATHOLOGY, Journal of magnetic resonance imaging, 6(1), 1996, pp. 190-194
Authors:
LOFTUS D
CASTELLI C
MARINCOLA F
PARMIANI G
APPELLA E
RIVOLTINI L
Citation: D. Loftus et al., A POSSIBLE ROLE FOR EPITOPE MIMICRY IN SHAPING THE CTL RESPONSE TO MELANOMA ANTIGEN MART-1, The FASEB journal, 10(6), 1996, pp. 2705-2705
Authors:
HIJAZI Y
FETSCH P
DURAY P
CORMIER J
MARINCOLA F
Citation: Y. Hijazi et al., IMMUNOCYTOCHEMICAL EVALUATION OF A NOVEL MELANOMA ANTIBODY, ANTI-MART-1 (M2-7, C10), Laboratory investigation, 74(1), 1996, pp. 230-230
Authors:
RIVOLTINI L
MANCINI M
MARKUS N
MARINCOLA F
ROSENBERG S
TOPALIAN S
Citation: L. Rivoltini et al., CHARACTERIZATION OF SHARED TUMOR-ANTIGENS RECOGNIZED BY MELANOMA-SPECIFIC CD4-CELLS( T), The FASEB journal, 8(4), 1994, pp. 10000209-10000209
Authors:
RESTIFO NP
KAWAKAMI Y
MARINCOLA F
SHAMAMIAN P
TAGGARSE A
ESQUIVEL F
ROSENBERG SA
Citation: Np. Restifo et al., MOLECULAR MECHANISMS USED BY TUMORS TO ESCAPE IMMUNE RECOGNITION - IMMUNOGENETHERAPY AND THE CELL BIOLOGY OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I, Journal of immunotherapy with emphasis on tumor immunology, 14(3), 1993, pp. 182-190